Skip to main navigation Skip to search Skip to main content

ABT-414 alone or ABT-414 plus temozolomide versus lomustine or temozolomide for recurrent glioblastoma: a randomized phase 11 study of the EORTC Brain Tumor Group

Project: Clinical studiesClinical Study (Industry project)

Project Details

Short titleINTELLANCE II / M14-483
StatusFinished
Effective start/end date12.05.201602.08.2021

Fields of science

  • 302052 Neurology
  • 302058 Palliative medicine
  • 302055 Oncology
  • 302030 Internal medicine